year-long wellness curriculum "Choose Wellness Emergency Medicine" at 5 emergency medicine residencies nationally. "Choose Wellness Emergency Medicine" included bimonthly structured didactic presentations, corresponding non-didactic elements, individualized interactive instruction (III) assignments, and additional Internet-based resources.
Study Objectives: There is evidence that oral anticoagulation (OAC) reduces stroke and mortality risk in patients with atrial fibrillation (AF); however, the clinical outcomes after a US emergency department (ED) evaluation for AF are unknown. This analysis seeks to determine the impact of early prescribing and long-term compliance of OAC on the rate of ischemic stroke and mortality after an ED evaluation for AF.
Methods: In this retrospective, Medicare, fee-for-service cohort of beneficiaries age 65, discharged from the ED from 2011-2012 with a new diagnosis of AF and no OAC prescription filled in the 90 days prior were included. Patients were stratified by filling of an OAC prescription (by any provider) within 10 days of ED diagnosis (early) versus not, and were considered compliant (80% medication possession ratio, MPR) versus non-compliant (<80% MPR) during their entire observed follow-up (time until the end of the study or time until their first event). Ischemic strokes were identified via ICD-9 codes from inpatient claims data and censored to the available data. Patients who had an adverse event before filling their early OAC prescription were excluded from the analysis. Descriptive statistics and Kaplan Meier curves with time to ischemic stroke were generated to compare patients with and without an early OAC.
Results: Of 9,139 with a new AF diagnosis, 24.1% were prescribed an early OAC. Patients with an early OAC were more likely to be younger (mean age early OAC 76.5 versus no early OAC 77.5 years), less likely to be female (58.1% versus 64.1%), and have a lower co-morbidity burden (mean Charlson score 2.7 versus 3.1) (all p<0.001). Among patients with early OACs, compliant patients (n¼1380) were older (77 versus 75.1 years), female (61.6% versus 52.1%), and higher stroke-risk with CHA 2 DS 2 -VASc (3.1 versus 2.7) (all p<0.001). During the study period, there were 133 (1.9%) ischemic stroke events in the group not treated with an early OAC as compared to 14 (1.0%) in the early OAC compliant and 14 (1.7%) in the early OAC non-compliant group (Figure) . In the no early OAC group, there were 665 deaths (9.6%), compared to 50 (3.6%) in early OAC compliant versus 33 (4.0%) in early OAC non-compliant.
Conclusions: In patients with a new diagnosis of AF, an early OAC in compliant patients may make a long-term impact on clinical outcomes and warrants further investigation in methods to improve early OAC prescribing.
Can Pharmacists Effectively Manage Blood Pressure for Discharged Urban Emergency Department Patients With Uncontrolled Hypertension?
Brody A, Stewart B, Zhang L, Levy P/Wayne State University, Detroit, MI Study Objectives: Uncontrolled hypertension (HTN) leads to severe cardiovascular morbidity, and is commonly encountered in emergency department (ED) practice. Linkage to primary care is elusive for many ED patients, specifically in underserved communities, and thus alternative modalities are needed. Pharmacist-led HTN medication management has proven effective for patients with uncontrolled BP. However, no studies to date have addressed the ability of pharmacists to manage HTN in ED patients post-discharge. The objective of this study is to assess the effectiveness of a pharmacist-led HTN management clinic in the ED population.
Methods: This a prospective, single arm trial of an innovative healthcare delivery system, a pharmacist-led HTN clinic. We recruited 89 patients with uncontrolled HTN, and lack of access to primary care from our urban ED from May 24, 2017 to May 18, 2018. Per protocol, 5 follow-up visits were planned in an outpatient pharmacy clinic, where antihypertensive medications were initiated and titrated by a pharmacist, under a collaborative agreement with emergency physicians. Information regarding the patient demographics and medical history were collected. Descriptive statistics were applied with graphic display of blood pressure change. These data represent an ad hoc, interim analysis of an ongoing study.
Results: The mean age was 42.5 years old (SD¼9.9); 51% were males; 94% were African American; 81% had 12 th grade or more education; 53% reported full-time employment and 18% had no health insurance. The mean BMI was 34.5 and 51.2% were current smokers. The median BP at ED admission was 160/102 mmHg. Of 89 patients recruited, only 32 (35%) actually attended the first visit. Both systolic and diastolic BP declined throughout the follow-up pharmacy clinic visits with the most impact on systolic BP (Figure) , which showed a mean decrease of 48 mmHg (95% confidence interval 20-77). The pharmacist made 47 medication interventions (initiation or titration) during 95 follow-up visits, for a rate of 0.49 interventions/visit. At protocol completion the mean number of antihypertensive medications per patient was 3.
Conclusions: Preliminary results show pharmacist-led HTN management provided to ED patients post-discharge is effective at lowering BP in a clinically meaningful manner. The pharmacist was proactive in medication titration, and patients received evidence based care. Linkage between recruitment in the ED, and actual study participation was suboptimal. These data are encouraging, and provide the rationale for future larger scale studies. To better understand the potential for clinical implementation, an exploration of factors influencing the effectiveness of treatment and a comparison with usual care are needed, with special attention paid to improving ED to pharmacy transition.
Conditions With Variation in Emergency Department Admission Rates Differ by Payer
Lin M, Richardson LD/Icahn School of Medicine at Mount Sinai, New York, NY Study Objectives: Hospital-based care accounts for one-third of national health expenditures, and prior research has demonstrated variation in ED admission rates for low-mortality, high-volume conditions. Existing policies are primarily focused on Medicare beneficiaries, due to payer policy and the increased risk associated with hospitalizing older adults. We aim to identify conditions with variation in ED admission rates by payer group and describe potential cost implications.
Methods: We performed a cross-sectional study of all statewide adult ED visits and hospitalizations by combing the 2014 Florida Healthcare Cost and Utilization Project (HCUP) State Emergency Department Databases and State Inpatient Databases. We stratified ED visits and admissions by primary discharge diagnosis and primary expected payer (Medicare, Medicaid, commercial, uninsured). We measured hospitallevel variation in ED admission rates among the most frequently admitted conditions by calculating unadjusted and risk-standardized admission rates using hierarchical logistic regression. We then applied hospital-specific cost-to-charge ratios to estimate potential cost savings for 3 scenarios in which variation is reduced (1) top quartile to median, 2) top quartile to 75 th percentile, 3) top quartile to 75 th percentile and lowest quartile to 25 th percentile). Results: Of the 1.2 million ED admissions in 2014, the most frequently admitted conditions were congestive heart failure (CHF, 89% ED admission rate), pneumonia (82.8%) and chronic obstructive pulmonary disease (COPD, 37.1%), while the conditions with greatest variation in hospital-level ED admissions were chest pain (median 14.5%, IQR 8-24), skin and soft tissue infection (SSTI, median 17.1%, IQR 13-25), and urinary tract infection (UTI, median 17.1%, IQR 13-25). Medicare (27.6%) and Medicaid (27.1%) accounted for the majority of ED visits and admissions, followed by commercial (23%) and uninsured/self-pay (16.2%). Among all payers, reducing hospital-level variation for CHF, UTI, and SSTI would produce the greatest savings in most scenarios. Conditions with highest potential for costsavings differed by payers: COPD (Medicare); CHF and UTI (Medicaid); UTI, chest pain and cardiac dysthymias (commercial); and SSTI (uninsured) . Conclusions: Reducing hospital-level variation in ED admission rates for highvolume, high-variation conditions such as SSTI, UTI and chest pain has the potential to produce significant cost savings for both public and private payers. These conditions have not been targeted by existing Medicare hospital value-based purchasing initiatives. Furthermore, conditions with the greatest potential to improve value for Medicaid and commercially insured beneficiaries overlap little with ambulatory care-sensitive conditions. Thus, policies to improve the value of acute care by reducing ED admissions do not appear to overlap with existing population health initiatives and may require targeted focus on ED transitions of care. Methods: Descriptions of all CMP settlements from 2002 to April 2018 related to EMTALA violations were obtained from the OIG. Characteristics of settlements including settlement date, location, amount, whether the settlement was against a hospital or individual physician, and nature of the allegation were described. Obstetrical-related cases were identified in settlement descriptions using keywords: pregnant, pregnancy, birth, and labor. Cases where the term "labor" was included in the CMP description as part of the acronym for EMTALA without relevance to an obstetrical context were not included.
Results: Of 229 total CMPs levied by the OIG during the study period, 38 (17%) were related to obstetrical emergencies. Three (8%) of the CMP settlements related to
